Ruxolitinib Significantly Enhances in Vitro Apoptosis in Hodgkin Lymphoma (HL) and Primary Mediastinal B-Cell Lymphoma (PMBL) and Survival in a Lymphoma Xenograft Murine Mouse: An AYA Therapeutic Opportunity

Authors

Selena Levine
Tishi Shah, New York Medical College
Jessica Hochberg, New York Medical CollegeFollow
Janet Ayello, New York Medical CollegeFollow
Erin Morris
Carmella van de Ven
Mitchell S. Cairo, New York Medical CollegeFollow

Author Type(s)

Faculty, Resident/Fellow

Document Type

Abstract

Publication Date

9-2018

DOI

10.1111/bjh.15536

Journal Title

British Journal of Haematology

Department

Pediatrics

Second Department

Health Behavior and Community Health

Recommended Citation

Levine, S., Shah, T., Hochberg, J., Ayello, J., Morris, E., van de Ven, C., & Cairo, M. S. (2018). Ruxolitinib Significantly Enhances in Vitro Apoptosis in Hodgkin Lymphoma (HL) and Primary Mediastinal B-Cell Lymphoma (PMBL) and Survival in a Lymphoma Xenograft Murine Mouse: An AYA Therapeutic Opportunity. British Journal of Haematology, 182 (Suppl.1), 37. https://doi.org/10.1111/bjh.15536